Premium
International consensus statement on allergy and rhinology: rhinosinusitis 2021
Author(s) -
Orlandi Richard R.,
Kingdom Todd T.,
Smith Timothy L.,
Bleier Benjamin,
DeConde Adam,
Luong Amber U.,
Poetker David M.,
Soler Zachary,
Welch Kevin C.,
Wise Sarah K.,
Adappa Nithin,
Alt Jeremiah A.,
AnselmoLima Wilma Terezinha,
Bachert Claus,
Baroody Fuad M.,
Batra Pete S.,
BernalSprekelsen Manuel,
Beswick Daniel,
Bhattacharyya Neil,
Chandra Rakesh K.,
Chang Eugene H.,
Chiu Alexander,
Chowdhury Naweed,
Citardi Martin J.,
Cohen Noam A.,
Conley David B.,
DelGaudio John,
Desrosiers Martin,
Douglas Richard,
Eloy Jean Anderson,
Fokkens Wytske J.,
Gray Stacey T.,
Gudis David A.,
Hamilos Daniel L.,
Han Joseph K.,
Harvey Richard,
Hellings Peter,
Holbrook Eric H.,
Hopkins Claire,
Hwang Peter,
Javer Amin R.,
Jiang RongSan,
Kennedy David,
Kern Robert,
Laidlaw Tanya,
Lal Devyani,
Lane Andrew,
Lee HeungMan,
Lee Jivianne T.,
Levy Joshua M.,
Lin Sandra Y.,
Lund Valerie,
McMains Kevin C.,
Metson Ralph,
Mullol Joaquim,
Naclerio Robert,
Oakley Gretchen,
Otori Nobuyoshi,
Palmer James N.,
Parikh Sanjay R.,
Passali Desiderio,
Patel Zara,
Peters Anju,
Philpott Carl,
Psaltis Alkis J.,
Ramakrishnan Vijay R.,
Ramanathan Murugappan,
Roh HwanJung,
Rudmik Luke,
Sacks Raymond,
Schlosser Rodney J.,
Sedaghat Ahmad R.,
Senior Brent A.,
Sindwani Raj,
Smith Kristine,
Snidvongs Kornkiat,
Stewart Michael,
Suh Jeffrey D.,
Tan Bruce K.,
Turner Justin H.,
Drunen Cornelis M.,
Voegels Richard,
Wang De Yun,
Woodworth Bradford A.,
Wormald PeterJohn,
Wright Erin D.,
Yan Carol,
Zhang Luo,
Zhou Bing
Publication year - 2021
Publication title -
international forum of allergy and rhinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.503
H-Index - 46
eISSN - 2042-6984
pISSN - 2042-6976
DOI - 10.1002/alr.22741
Subject(s) - rhinology , medicine , executive summary , statement (logic) , medline , evidence based medicine , chronic rhinosinusitis , family medicine , alternative medicine , otorhinolaryngology , pathology , surgery , microbiology and biotechnology , political science , law , biology
I. Executive Summary Background The 5 years since the publication of the first International Consensus Statement on Allergy and Rhinology: Rhinosinusitis (ICAR‐RS) has witnessed foundational progress in our understanding and treatment of rhinologic disease. These advances are reflected within the more than 40 new topics covered within the ICAR‐RS‐2021 as well as updates to the original 140 topics. This executive summary consolidates the evidence‐based findings of the document. Methods ICAR‐RS presents over 180 topics in the forms of evidence‐based reviews with recommendations (EBRRs), evidence‐based reviews, and literature reviews. The highest grade structured recommendations of the EBRR sections are summarized in this executive summary. Results ICAR‐RS‐2021 covers 22 topics regarding the medical management of RS, which are grade A/B and are presented in the executive summary. Additionally, 4 topics regarding the surgical management of RS are grade A/B and are presented in the executive summary. Finally, a comprehensive evidence‐based management algorithm is provided. Conclusion This ICAR‐RS‐2021 executive summary provides a compilation of the evidence‐based recommendations for medical and surgical treatment of the most common forms of RS.